Cite
APA Citation
Villafane, G., Thiriez, C., Audureau, E., Straczek, C., Kerschen, P., Cormier‐Dequaire, F., Van Der Gucht, A., Gurruchaga, J., Quéré‐Carne, M., Evangelista, E., Paul, M., Defer, G., Damier, P., Remy, P., Itti, E., & Fénelon, G. (2018). high‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study. European journal of neurology, 25, 120–127. http://access.bl.uk/ark:/81055/vdc_100054863010.0x000023